dc.contributor.author | World Health Organization. Regional Office for the Western Pacific | |
dc.coverage.spatial | Manila | |
dc.date.accessioned | 2018-06-07T06:36:50Z | |
dc.date.accessioned | 2018-06-10T20:05:27Z | |
dc.date.available | 2018-06-07T06:36:50Z | |
dc.date.available | 2018-06-10T20:05:27Z | |
dc.date.issued | 2017 | |
dc.identifier.uri | http://iris.wpro.who.int/handle/10665.1/14095 | |
dc.identifier.uri | https://iris.who.int/handle/10665/272805 | |
dc.description | 17 p. | en |
dc.language.iso | en | en |
dc.publisher | WHO Regional Office for the Western Pacific | en |
dc.relation.ispartofseries | Report series ; RS/2017/GE/46(PHL) | |
dc.subject.mesh | Hepatitis | en |
dc.subject.mesh | Drugs, Essential | en |
dc.subject.mesh | Health Services Accessibility | en |
dc.title | Informal Consultation on Access to Hepatitis Medicines in Upper-Middle- and High-Income Countries, Manila, Philippines, 21-22 August 2017 : meeting report | en |
dc.type | Technical documents | en |
wpro.contributor.coauthor | Informal Consultation on Access to Hepatitis Medicines in Upper-Middle- and High-Income Countries (2017 : Manila, Philippines) | |
wpro.description.location | Manila, Philippines | en |